Evotec partners with Crohn’s & Colitis Foundation for IBD therapies

Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.

Jan 11, 2024 - 18:00

Evotec partners with Crohn’s & Colitis Foundation for IBD therapies

Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.

Read the original article

Tags:

Previous Article

BridgeBio gears up for FDA review of acoramidis following Phase III results

3M Health receives grant to develop wound treatment solutions in US

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Galecto terminates development for its lead candidate

Galecto terminates development for its lead candidate

Aug 16, 2023

Inline, real-time PAT tool is a game-changer for pharma granulation sector

Inline, real-time PAT tool is a game-changer for pharma...

Jun 4, 2024

STAT+: As digital health tech proliferates, a new institute aims to cut through hype

STAT+: As digital health tech proliferates, a new insti...

Jul 18, 2023